CD22-targeted glyco-engineered natural killer cells offer a further treatment option for B-cell acute lymphoblastic leukemia

Xin Jin(Tianjin First Center Hospital), Mingfeng Zhao(Tianjin First Center Hospital), Hairong Lyu(University of Bristol), Wenyi Lu(Tianjin First Center Hospital), Zhihong Fang(The University of Texas MD Anderson Cancer Center), Xianwu Wang(Xiamen University of Technology), Li Zhu(Soochow University), Hongkai Zhang(Nanchang University), Xiong Xia(Guizhou Normal University), Rui Sun(Jiangsu University), Yunpeng Tian(Tianjin First Center Hospital), Xia Xiao(Jilin University), Luqiao Wang(Sir Run Run Shaw Hospital)
Haematologica
May 2, 2024
10.3324/haematol.2023.284241
Cited by 3

Related Papers

Single‐Junction Organic Solar Cells with 19.17% Efficiency Enabled by Introducing One Asymmetric Guest Acceptor
|Advanced Materials|2022|620
Fine-Tuning Energy Levels via Asymmetric End Groups Enables Polymer Solar Cells with Efficiencies over 17%
|Joule|2020|417
A Layer-by-Layer Architecture for Printable Organic Solar Cells Overcoming the Scaling Lag of Module Efficiency
|Joule|2020|384
Achieving over 17% efficiency of ternary all-polymer solar cells with two well-compatible polymer acceptors
|Joule|2021|378
Desired open-circuit voltage increase enables efficiencies approaching 19% in symmetric-asymmetric molecule ternary organic photovoltaics
|Joule|2022|348